Tobramycin once- vs thrice-daily for elective intravenous antipseudomonal therapy in pediatric cystic fibrosis patients

被引：0
|
作者：
J. Riethmueller
M. Ballmann
T. W. Schroeter
P. Franke
R. von Butler
A. Claass
S. Junge
G. Doering
M. Stern
机构：
[1] University Children’s Hospital,Pediatric Dept.
[2] University Children’s Hospital Kiel,undefined
[3] University of Hannover,undefined
[4] Hygiene-Institut,undefined
[5] University of Tübingen,undefined
来源：
Infection | 2009年 / 37卷
关键词：
Ceftazidime; Tobramycin; Cystic Fibrosis Patient; Postantibiotic Effect; Multiple Daily Dose;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：424 / 431
页数：7
相关论文
共 48 条
  • [21] Once daily tobramycin achieves cidal levels against Pseudomonas aeruginosa in patients with cystic fibrosis
    Smyth, A
    Doherty, C
    Govan, J
    Tan, K
    Hyman-Taylor, P
    Stableforth, D
    Diver, C
    Knox, A
    THORAX, 2001, 56 : 84 - 84
  • [22] OUTCOME DETERMINATIONS UTILIZING TWICE DAILY TOBRAMYCIN DOSING IN PEDIATRIC CYSTIC FIBROSIS PATIENTS
    Geist, A.
    Hayes, D.
    Davis, G.
    Kanga, J.
    Anstead, M.
    Kuhn, R.
    PEDIATRIC PULMONOLOGY, 2009, : 323 - 323
  • [23] ONCE-DAILY VERSUS THRICE-DAILY DOSING OF NETILMICIN IN COMBINATION WITH BETA-LACTAM ANTIBIOTICS AS EMPIRICAL THERAPY FOR FEBRILE NEUTROPENIC PATIENTS
    ROZDZINSKI, E
    KERN, WV
    REICHLE, A
    MORITZ, T
    SCHMEISER, T
    GAUS, W
    KURRLE, E
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 31 (04) : 585 - 598
  • [24] Once-Daily Gentamicin Dosing in Pediatric Patients Without Cystic Fibrosis
    McDade, Erin J.
    Wagner, Jeffrey L.
    Moffett, Brady S.
    Palazzi, Debra L.
    PHARMACOTHERAPY, 2010, 30 (03): : 248 - 253
  • [25] SAFETY OF ONCE DAILY TOBRAMYCIN DOSING IN CYSTIC FIBROSIS PATIENTS LESS THAN 5 YEARS OLD
    Pettit, R. S.
    McCrory, B. E.
    Elson, E.
    Stone, C.
    Lubsch, L.
    McDade, E. J.
    Kemper, A.
    Stockmann, C.
    Zobell, J.
    PEDIATRIC PULMONOLOGY, 2017, 52 : S358 - S358
  • [26] Comparing Dosage Adjustment Methods for Once-Daily Tobramycin in Paediatric and Adolescent Patients with Cystic Fibrosis
    Stefanie Hennig
    Franziska Holthouse
    Christine E. Staatz
    Clinical Pharmacokinetics, 2015, 54 : 409 - 421
  • [27] EFFECT OF ONCE-DAILY TOBRAMYCIN FOR CYSTIC FIBROSIS PATIENTS ON A PHARMACIST-MANAGED AMINOGLYCOSIDE PROTOCOL
    McDade, E. J.
    Haberman, B. K.
    Hiatt, P. W.
    Oermann, C. M.
    PEDIATRIC PULMONOLOGY, 2011, : 309 - 309
  • [28] Comparing Dosage Adjustment Methods for Once-Daily Tobramycin in Paediatric and Adolescent Patients with Cystic Fibrosis
    Hennig, Stefanie
    Holthouse, Franziska
    Staatz, Christine E.
    CLINICAL PHARMACOKINETICS, 2015, 54 (04) : 409 - 421
  • [29] TWICE DAILY DOSING OF TOBRAMYCIN IMPROVES ATTAINMENT OF PHARMACOKINETIC PARAMETERS IN PEDIATRIC PATIENTS WITH CYSTIC FIBROSIS
    Turner, R.
    Biondo, L. R.
    PEDIATRIC PULMONOLOGY, 2013, 48 : 326 - 326
  • [30] Absence of cochleotoxicity measured by standard and high-frequency pure tone audiometry in a trial of once- versus three-times-daily tobramycin in cystic fibrosis patients
    Mulheran, Michael
    Hyman-Taylor, Pauline
    Tan, Kelvin H. -V.
    Lewis, Sarah
    Stableforth, David
    Knox, Alan
    Smyth, Alan
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (07) : 2293 - 2299
12345